Simon Michael S, Raychaudhuri Sreejata, Hamel Lauren M, Penner Louis A, Schwartz Kendra L, Harper Felicity W K, Thompson Hayley S, Booza Jason C, Cote Michele, Schwartz Ann G, Eggly Susan
Department of Oncology, Wayne State University, Detroit, MI, United States.
Population Studies and Disparities Research Program, Karmanos Cancer Institute, Detroit, MI, United States.
Front Oncol. 2021 Jul 7;11:690390. doi: 10.3389/fonc.2021.690390. eCollection 2021.
Racial disparities in cancer incidence and outcomes are well-documented in the US, with Black people having higher incidence rates and worse outcomes than White people. In this review, we present a summary of almost 30 years of research conducted by investigators at the Karmanos Cancer Institute's (KCI's) Population Studies and Disparities Research (PSDR) Program focusing on Black-White disparities in cancer incidence, care, and outcomes. The studies in the review focus on individuals diagnosed with cancer from the Detroit Metropolitan area, but also includes individuals included in national databases. Using an organizational framework of three generations of studies on racial disparities, this review describes racial disparities by primary cancer site, disparities associated with the presence or absence of comorbid medical conditions, disparities in treatment, and disparities in physician-patient communication, all of which contribute to poorer outcomes for Black cancer patients. While socio-demographic and clinical differences account for some of the noted disparities, further work is needed to unravel the influence of systemic effects of racism against Black people, which is argued to be the major contributor to disparate outcomes between Black and White patients with cancer. This review highlights evidence-based strategies that have the potential to help mitigate disparities, improve care for vulnerable populations, and build an equitable healthcare system. Lessons learned can also inform a more equitable response to other health conditions and crises.
癌症发病率和治疗结果方面的种族差异在美国有充分记录,黑人的发病率高于白人,治疗结果也更差。在这篇综述中,我们总结了卡曼诺斯癌症研究所(KCI)人口研究与差异研究(PSDR)项目的研究人员近30年的研究,这些研究聚焦于癌症发病率、治疗和结果方面的黑白差异。综述中的研究主要针对底特律都会区被诊断患有癌症的个体,但也包括纳入国家数据库的个体。本综述采用关于种族差异的三代研究的组织框架,描述了按主要癌症部位划分的种族差异、与有无合并症相关的差异、治疗差异以及医患沟通差异,所有这些都导致黑人癌症患者的治疗结果更差。虽然社会人口统计学和临床差异可以解释部分已指出的差异,但仍需进一步研究,以揭示种族主义对黑人的系统性影响,这种影响被认为是导致黑人和白人癌症患者治疗结果存在差异的主要原因。本综述强调了一些基于证据的策略,这些策略有可能帮助减少差异,改善对弱势群体的治疗,并建立一个公平的医疗体系。吸取的经验教训也可为更公平地应对其他健康状况和危机提供参考。